EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating cancer screening programs using survival analysis

Bor Vratanar iD, Maja Pohar Perme iD

Biometrical Journal · 2023-10 · 65 (7)

DOI: 10.1002/bimj.202200344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrical Journal, online erschienen am 06.06.2023. Verfasst von Bor Vratanar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Javna Agencija za Raziskovalno Dejavnost RS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main purpose of cancer screening programs is to provide early treatment to patients that are diagnosed with cancer on a screening test, thus increasing their chances of survival. To test this hypothesis directly, one should compare the survival of screen‐detected cases to the survival of their counterparts not included to the program. In this study, we develop a general notation and use it to formally define the comparison of interest. We explain why the naive comparison between screen‐detected and interval cases is biased and show that the total bias that arises in this case can be decomposed as a sum of lead time bias, length time bias, and bias due to overdetection. With respect to the estimation, we show what can be estimated using existing methods. To fill in the missing gap, we develop a new nonparametric estimator that allows us to estimate the survival of the control group, that is, the survival of cancer cases that would be screen‐detected among those not included to the program. By joining the proposed estimator with existing methods, we show that the contrast of interest can be estimated without neglecting any of the biases. Our approach is illustrated using simulations and empirical data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBreast NeoplasmsHumansFemaleMass ScreeningEarly Detection of CancerSurvival AnalysisBias

Stichwörter der Autor:innen

biasbreast cancercancer screeningcounterfactualsurvival analysis

Autor:innen und Institutionen

  • Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Bor Vratanar, Maja Pohar Perme

Förderung

  • Javna Agencija za Raziskovalno Dejavnost RS

Zitieren

APA

Vratanar, B., & Pohar Perme, M. (2023). Evaluating cancer screening programs using survival analysis. Biometrical Journal, 65(7). https://doi.org/10.1002/bimj.202200344

Vancouver

Vratanar B, Pohar Perme M. Evaluating cancer screening programs using survival analysis. Biometrical Journal. 2023;65(7). doi:10.1002/bimj.202200344

BibTeX
@article{Vratanar2023,
  author = {Vratanar, Bor and Pohar Perme, Maja},
  title = {Evaluating cancer screening programs using survival analysis},
  journal = {Biometrical Journal},
  year = {2023},
  volume = {65},
  number = {7},
  doi = {10.1002/bimj.202200344}
}
Kostenlos starten →